SCHEMBL15036581

SCHEMBL15036581

CCN1CCN(C(=O)c2ccccc2)C[C@H]1C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 1/20 0.61
▸ BLM P54132 1/20 0.55
▸ ACHE P22303 1/20 0.53
▸ DRD3 P35462 1/20 0.52
▸ P2RX7 Q99572 1/20 0.51
▸ SMO Q99835 4/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ SLC6A7 Q99884 1/20 0.50
▸ FNTA P49354 1/20 0.49
▸ FNTB P49356 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ PLA2G1B P04054 1/20 0.48
▸ ATG4B Q9Y4P1 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4066456 0.83 DRD3 (0.48) CHRM1BLMACHEDRD3SMO
SCHEMBL4063619 0.83 DRD3 (0.48) CHRM1BLMACHEDRD3SMO
SCHEMBL13655443 0.83 DRD3 (0.48) CHRM1BLMACHEDRD3SMO
SCHEMBL14414557 0.80 ACHE (0.57) BLMACHESMOCYP2D6CYP2C9
SCHEMBL14414234 0.80 CHRM1 (0.57) CHRM1BLMACHESMOCYP2D6
SCHEMBL15036555 0.80 CHRM1 (0.57) CHRM1BLMACHESMOCYP2D6
SCHEMBL29748819 0.78 GFER (0.63) ACHESMOSLC6A7SMN1; SMN2
SCHEMBL17086794 0.78 HDAC1 (0.53) DRD3SMO
Hydrochloric Acid SCHEMBL31587034 0.78 MEN1 (0.59) SMOKMT2ASMN1; SMN2HTTALDH1A1
SCHEMBL16259102 0.77 ACHE (0.53) BLMACHESMOCYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013090696-A1 CD4-MIMETIC INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2013-06-20 — — WO disclosed
Send feedback